Medical Nutrition Market, By Nutrition Type (Proteins, Carbohydrates, Multivitamins & Antioxidants, Amino Acids, Fibers, Minerals, and Others), By Indication (Diabetes, Cancer, Gastrointestinal Diseases, Metabolic Syndromes, and Others), By Patient Type (Infant Nutrition, Adult Nutrition, and Geriatric Nutrition), By Route of Administration (Oral, Enteral, and Parenteral), By End User (Hospitals, Home Care Settings, Long Term Care, and Ambulatory Surgical Centers), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
In November 2023, Danone S.A., a global medical nutrition company, announced that it had launched Fortimel medical nutrition product in the adult Foods for Special Medical Purposes category in China. Fortimel is designed to meet the nutritional needs of patients recovering after surgery or non-communicable diseases like cancer and stroke and complements Danone’s existing offering of adult medical nutrition for tube-feeding.
In November 2022, Nestlé, a multinational food and drink processing company, announced that it had built a new research and development facility in Brazil for the development of affordable, sustainable nutritional products for people living in Latin America
In September 2022, Abbott, a company developing innovative and science-based nutrition products, announced the launch of Similac GainSchool, the first and only milk formula with the PRODI-G Nutrient System and an exclusive blend of five different human milk oligosaccharides (HMOs) to support better brain connections, higher IQ, and stronger immunity
In April 2022, Fresenius Kabi Ltd, a global healthcare company, announced the launch of its UK and ROI Enteral Nutrition Product App. The Enteral Nutrition Product App makes it easier to access detailed product information and includes a quick comparison tool to compare nutritional values against reference nutrient intakes.
In April 2020, Esperer Onco Nutrition, a start-up company, launched a range of nutrition supplements for cancer patients at different stage of treatment